Latest Italy News

ADX Energy reported a 23% rise in production to 303 BOEPD for Q2 2025, offsetting a 10% drop in Brent oil prices, while advancing key drilling plans and awaiting new permit awards.

Altamin Limited progresses its innovative Lazio lithium and sulphate of potash project with key engineering studies underway, while its Gorno base metals project reports exceptional zinc, lead, and silver assay results, setting the stage for strategic partnership discussions.

Po Valley Energy reports steady gas production from its Podere Maiar-1 field and progresses permitting for new wells in Italy, supported by robust cash reserves and ongoing stakeholder engagement.

Fluence Corporation Limited reported a positive net operating cash flow of US$5.1 million for Q2 2025, boosting its cash reserves to US$12.7 million and maintaining solid liquidity through revolving credit and loan facilities.

Alligator Energy reports a 10% increase in indicated uranium resources at its Samphire Project, secures a $17.25 million capital raise, and announces a CEO transition as it advances key uranium exploration and development milestones.

Vection Technologies has landed a $4 million contract with Italy’s Omniacom Group to deploy its AI-integrated extended reality solutions across multiple sectors, marking a milestone in its European expansion.

Po Valley Energy appoints its largest shareholder Kevin Bailey AM as Executive Chair and CEO, aiming to accelerate natural gas production growth in Italy amid strong financial footing.

Vection Technologies has secured a $2.6 million contract to co-develop SAFE-XR, an AI-powered safety compliance platform using augmented reality and wearable tech for industrial inspections in Italy.

Vection Technologies has launched its Algho AI Sign Language solution on Amazon Web Services Marketplace, targeting enhanced accessibility across Europe. Early contracts signal strong market interest in AI-driven communication tools for the Deaf and hard-of-hearing community.

OncoSil Medical has launched a Security Purchase Plan offering discounted shares and free options to eligible shareholders, aiming to accelerate commercialization of its pancreatic cancer treatment device.

OncoSil Medical has secured $8.7 million through a placement and share purchase plan to fund commercialization of its pancreatic cancer treatment device, aiming for positive cash flow by mid-2026. Near-completion clinical trials could soon unlock broader market access.

Altamin Limited has reported the final tranche of high-grade zinc-lead-silver assay results from its 2024 channel sampling at the Gorno Project, revealing mineralisation beyond current resource boundaries. These findings highlight new zones in previously inaccessible areas, reinforcing the project's exploration potential.